Retatrutide has emerged as a new medication in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, exhibits promising results in clinical trials. By activating these https://philipsfnx080609.liberty-blog.com/36393349/retatrutide-a-promising-new-treatment-for-obesity